News


    The Department of Health and Human Services has announced it will soon provide $485 million in grants to help states and territories combat the opioid crisis. The funding, which is the first of two rounds provided for in the 21st Century Cures Act, will be provided through State Targeted Response to the Opioid Crisis Grants […]

    Read the full story

    Public Health Department’s Three-Pronged Strategy Opioids have emerged as one of the greatest public health threats facing the United States. Nationally, fatal overdoses involving opioids have quadrupled since 1999. Opioids contributed to over 33,000 deaths in 2015 alone. In Philadelphia, the numbers are equally sobering. Although the final toxicology reports are pending, approximately 900 deaths […]

    Read the full story

    Public health officials, elected leaders and medical professionals across New York State gathered in Albany, New York on February 7, 2017 to discuss hepatitis C in the state for the first ever New York State hepatitis C virus (HCV) summit. In a consensus statement, the committee that organized the summit called on Governor Andrew Cuomo […]

    Read the full story

    What if there was a disease affecting 27.1 million people in the United States, that killed over 33,000 people in one year or about 91 people a day? What if this same disease cost the United States healthcare system about $78.5 billion? What if researchers could not study this disease in order to provide information […]

    Read the full story

    The Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV (CHERISH) was profiled at the Liver Meeting® 2016 in Boston, MA. The Center’s mission is to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors that informs substance use disorder treatment policy and HCV and […]

    Read the full story

    The US Panel on Cost-Effectiveness in Health and Medicine issued a report in 1996 that set the standards for reporting of cost-effectiveness studies in the field, resulting in a rapid expansion of publications and establishment of similar national standards in other jurisdictions. Twenty years later, the Second Panel on Cost-Effectiveness in Health and Medicine has […]

    Read the full story